Physician profile
Brian K Estwick
NPI 1003889247
$498.55
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $222 · 2021: $20.23 · 2022: $27.93.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $250.32 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $64.48 | 2020-2021 | |
| Alcon Vision LLC | $52.60 | 2019 | |
| Allergan, INC. | $39.17 | 2019-2020 | |
| Abbvie INC. | $27.93 | 2022 | |
| Omeros Corporation | $20.70 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.05 | 2020 | |
| Shire North American Group INC | $15.17 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.13 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Estwick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.